Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

NCT03475212 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections
Adenovirus Infection
EBV Infection

Interventions

BIOLOGICAL: Virus Specific T-cell (VST) infusion

Sponsor

Pediatric Transplantation & Cellular Therapy Consortium